Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases.

[1]  A. Berezin,et al.  Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients. , 2015, Journal of cardiology.

[2]  A. Berezin,et al.  Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes , 2014, International cardiovascular research journal.

[3]  Martin McKee,et al.  Cardiovascular risk and events in 17 low-, middle-, and high-income countries. , 2014, The New England journal of medicine.

[4]  M. Doherty,et al.  Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications? , 2014, Biochemical Society transactions.

[5]  G. M. Allan,et al.  Comparison of cardiovascular disease risk calculators , 2014, Current opinion in lipidology.

[6]  D. Pisetsky,et al.  The Expression of HMGB1 on Microparticles from Jurkat and HL‐60 Cells Undergoing Apoptosis in vitro , 2014, Scandinavian journal of immunology.

[7]  K. Poh,et al.  Endothelial progenitor cells in cardiovascular diseases. , 2014, World journal of stem cells.

[8]  O. Lee,et al.  Role of tumour necrosis factor receptor-1 and nuclear factor-κB in production of TNF-α-induced pro-inflammatory microparticles in endothelial cells , 2014, Thrombosis and Haemostasis.

[9]  F. Carrasco-Sánchez,et al.  Review of the Prognostic Value of Galectin-3 in Heart Failure Focusing on Clinical Utility of Repeated Testing , 2014, Molecular Diagnosis & Therapy.

[10]  Cynthia Balion,et al.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure , 2014, Heart Failure Reviews.

[11]  J. Spence,et al.  Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction. , 2014, Swiss medical weekly.

[12]  M. Ravera,et al.  High performance of a risk calculator that includes renal function in predicting mortality of hypertensive patients in clinical application , 2014, Journal of hypertension.

[13]  A. Falus,et al.  Emerging role of extracellular vesicles in inflammatory diseases , 2014, Nature Reviews Rheumatology.

[14]  S. Mornet,et al.  Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration , 2014, Journal of thrombosis and haemostasis : JTH.

[15]  R. Andriantsitohaina,et al.  Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components. , 2014, Current vascular pharmacology.

[16]  N. Mackman,et al.  New players in haemostasis and thrombosis , 2014, Thrombosis and Haemostasis.

[17]  D. Pisetsky,et al.  The properties of microparticles from RAW 264.7 macrophage cells undergoing in vitro activation or apoptosis , 2014, Innate immunity.

[18]  H. Lehnert,et al.  Using annexin V‐coated magnetic beads to capture active tissue factor‐bearing microparticles from body fluids , 2014, Cell biology international.

[19]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[20]  A. Tedgui,et al.  Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases , 2014, Circulation research.

[21]  C. Tseng,et al.  Four-Variable Risk Model in Men and Women With Heart Failure , 2014, Circulation. Heart failure.

[22]  S. Umemura,et al.  Peripheral Endothelial Function and Cardiovascular Events in High‐Risk Patients , 2013, Journal of the American Heart Association.

[23]  G. Nickenig,et al.  Abstract 10882: Endothelial Microparticle-mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair Via SPRED1 and is Abrogated in Glucose-damaged Endothelial Microparticles , 2013 .

[24]  Daniel P. Credeur,et al.  Impact of reduced daily physical activity on conduit artery flow-mediated dilation and circulating endothelial microparticles. , 2013, Journal of applied physiology.

[25]  Gautam Sethi,et al.  The Vascular Endothelium and Human Diseases , 2013, International journal of biological sciences.

[26]  M. Markiewicz,et al.  Impact of Endothelial Microparticles on Coagulation, Inflammation, and Angiogenesis in Age-Related Vascular Diseases , 2013, Journal of aging research.

[27]  Shuzhen Chen,et al.  Effects of Endothelial Progenitor Cell-Derived Microvesicles on Hypoxia/Reoxygenation-Induced Endothelial Dysfunction and Apoptosis , 2013, Oxidative medicine and cellular longevity.

[28]  Romaric Lacroix,et al.  Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. , 2013, Journal of the American College of Cardiology.

[29]  T. Arentz,et al.  Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity. , 2013, International journal of cardiology.

[30]  Hongwei Xu,et al.  Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein , 2013, Molecular Biology Reports.

[31]  G. Guyatt,et al.  Risk Prediction Models for Mortality in Ambulatory Patients With Heart Failure: A Systematic Review , 2013, Circulation. Heart failure.

[32]  Chia-Hung Chiang,et al.  Increased Circulating Endothelial Apoptotic Microparticle to Endothelial Progenitor Cell Ratio Is Associated with Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients , 2013, PloS one.

[33]  Mark D. Huffman,et al.  Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020 , 2013, Circulation.

[34]  M. Nelson,et al.  Primary prevention of cardiovascular disease: new guidelines, technologies and therapies , 2013, The Medical journal of Australia.

[35]  M. Boucekine,et al.  Standardization of pre‐analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2013, Journal of thrombosis and haemostasis : JTH.

[36]  W. Shim,et al.  Endothelial microparticles: missing link in endothelial dysfunction? , 2013, European journal of preventive cardiology.

[37]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[38]  Hai-Yun Yuan,et al.  Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function. , 2013, American journal of physiology. Endocrinology and metabolism.

[39]  Nikos Werner,et al.  High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. , 2013, Cardiovascular research.

[40]  S. Manzano-Fernández,et al.  Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. , 2013, Atherosclerosis.

[41]  I. Bruce,et al.  Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotective. , 2013, Clinical and experimental rheumatology.

[42]  Daniel P. Credeur,et al.  Disturbed Blood Flow Acutely Induces Activation and Apoptosis of the Human Vascular Endothelium , 2013, Hypertension.

[43]  M. Alessi,et al.  Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells , 2012, Journal of cellular and molecular medicine.

[44]  N. Lion,et al.  Red blood cell microparticles and blood group antigens: an analysis by flow cytometry. , 2012, Blood transfusion = Trasfusione del sangue.

[45]  Christian Jung,et al.  Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. , 2012, Atherosclerosis.

[46]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[47]  R. Andriantsitohaina,et al.  Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells , 2011, Fundamental & clinical pharmacology.

[48]  G. Davis,et al.  Blood coagulation and blood vessel development: is tissue factor the missing link? , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[49]  A. Maisel.  Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research. , 2011, Journal of the American College of Cardiology.

[50]  A. Simon,et al.  Microparticles, Vascular Function, and Atherothrombosis , 2011, Circulation research.

[51]  R. Touyz,et al.  Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[52]  S. Hohnloser,et al.  Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation , 2011, Clinical Research in Cardiology.

[53]  R. Andriantsitohaina,et al.  Microparticles in angiogenesis: therapeutic potential. , 2011, Circulation research.

[54]  N. Mackman,et al.  Microparticles in Hemostasis and Thrombosis , 2011, Circulation research.

[55]  A. Schoenenberger,et al.  T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis. , 2011, European heart journal.

[56]  Y. Castier,et al.  Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1–Dependent Monocyte Adhesion and Transendothelial Migration , 2011, Circulation research.

[57]  J. Badimón,et al.  Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? , 2011, Internal and emergency medicine.

[58]  R. Nieuwland,et al.  Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease: Friend or Foe? , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[59]  C. Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[60]  R. Sacco,et al.  Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus. , 2010, Metabolism: clinical and experimental.

[61]  Shao-Sung Huang,et al.  Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria , 2010, Journal of hypertension.

[62]  P. Brunet,et al.  Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis , 2010, Thrombosis and Haemostasis.

[63]  L. Ragolia,et al.  Circulating Endothelial Microparticles in Diabetes Mellitus , 2010, Mediators of inflammation.

[64]  D. O'Gorman,et al.  The endothelial microparticle response to a high fat meal is not attenuated by prior exercise , 2009, European Journal of Applied Physiology.

[65]  J. Edelberg,et al.  p38 mitogen‐activated protein kinase targets the production of proinflammatory endothelial microparticles , 2009, Journal of thrombosis and haemostasis : JTH.

[66]  K. Fukudome,et al.  Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects , 2009, Haematologica.

[67]  A. Enjeti,et al.  Microparticles in health and disease. , 2008, Seminars in thrombosis and hemostasis.

[68]  K. Pritchard,et al.  Comparative proteomic analysis of PAI‐1 and TNF‐alpha‐derived endothelial microparticles , 2008, Proteomics.

[69]  R. Paltriccia,et al.  Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. , 2008, Atherosclerosis.

[70]  O. Morel,et al.  [Markers of thrombotic disease: procoagulant microparticles]. , 2007, Annales pharmaceutiques francaises.

[71]  O. Morel,et al.  Marqueurs des pathologies thrombotiques: Les microparticules procoagulantes☆ , 2007 .

[72]  K. Pritchard,et al.  ENDOTHELIUM-DERIVED MICROPARTICLES INDUCE ENDOTHELIAL DYSFUNCTION AND ACUTE LUNG INJURY , 2006, Shock.

[73]  J. Freyssinet,et al.  Procoagulant Microparticles: ‘Criminal Partners’ in Atherothrombosis and Deleterious Cellular Exchanges , 2006, Pathophysiology of Haemostasis and Thrombosis.

[74]  V. Faure,et al.  Elevation of circulating endothelial microparticles in patients with chronic renal failure , 2006, Journal of thrombosis and haemostasis : JTH.

[75]  Roeland M. H. Merks,et al.  Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. , 2005, American journal of physiology. Heart and circulatory physiology.

[76]  N. Huh,et al.  Expression of developmentally regulated endothelial cell locus 1 was induced by tumor-derived factors including VEGF. , 2005, Biochemical and biophysical research communications.

[77]  R. Nieuwland,et al.  Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.

[78]  L. Horstman,et al.  Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.

[79]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[80]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.

[81]  M. Golightly,et al.  Plasminogen Activator Inhibitor-1 Promotes Formation of Endothelial Microparticles With Procoagulant Potential , 2002, Circulation.

[82]  F. Dignat-George,et al.  Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. , 2002, Blood.

[83]  Yu-qi Fan,et al.  Quantification of endothelial microparticles on modified cytometric bead assay and prognosis in chest pain patients. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[84]  A. Berezin,et al.  The Biomarker Risk Prediction Score in Chronic Heart , 2014 .

[85]  W. Daniel,et al.  Shear stress patterns affect the secreted chemokine profile in endothelial cells. , 2012, Clinical hemorheology and microcirculation.

[86]  L. Pierelli,et al.  Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with β-thalassaemia. , 2012, Blood transfusion = Trasfusione del sangue.

[87]  Y. Ikeda,et al.  Function and role of microparticles in various clinical settings. , 2008, Thrombosis research.

[88]  A. Leroyer,et al.  [Circulating endothelial microparticles: a new marker of vascular injury]. , 2008, Annales de cardiologie et d'angeiologie.

[89]  A. Simon,et al.  Endothelial microparticles in diseases , 2008, Cell and Tissue Research.

[90]  R. Andriantsitohaina,et al.  Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. , 2008, Pharmacological reports : PR.

[91]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Endothelial cell-derived microparticles , 2007 .

[92]  A. Koong,et al.  Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. , 2007, Cancer research.